ShuYu Civilian Pharmacy Corp., Ltd.

ShuYu Civilian Pharmacy Corp., Ltd. is a retail company listed on the ChiNext board of the Shenzhen Stock Exchange since 2021. The company primarily operates a pharmaceutical retail chain that caters to individual consumers, offering a range of products including Chinese and Western patent medicines, health foods, Chinese medicine slices, and health equipment. ShuYu employs a retail business model that involves uniform procurement and pricing strategies across its stores, ensuring that end consumers receive consistent product offerings. The company's operations extend across several provinces in China, including Shandong, Liaoning, Heilongjiang, Fujian, Henan, Gansu, Jilin, and Shaanxi. In addition to its retail operations, ShuYu has developed a wholesale franchise business since late 2019 to adapt to industry trends. The company utilizes a combination of centralized and regional procurement models to optimize its supply chain and distribution, which includes both independent and entrusted distribution methods. As the company continues to expand, it has gained recognition within the pharmaceutical retail sector, enhancing its brand influence and corporate reputation.

At present, the company's business scope covers provinces such as Shandong, Liaoning, Heilongjiang, Fujian, Henan, Gansu, Jilin, and Shaanxi. With the continuous expansion of the company's business scale, its brand influence and corporate reputation have been constantly improving. It has been ranked among the top ten in China's chain pharmacy rankings for many consecutive years. According to the "2025 China Pharmaceutical Retail Comprehensive Competitiveness Top 100 List" released by the China Health Industry Research Institute at the Xipu Conference, the company ranked 9th; in the 2024 sales total ranking of the pharmaceutical retail industry released by the China Pharmaceutical Commerce Association, the company was among the top ten; in the "Top 100 Value List of Chinese Pharmacies" organized by China Pharmacy Magazine, the company ranked 8th in the 2024-2025 value list.